LAG3 and breast cancer: However, some studies arrived at the seemingly opposite conclusion that high expression of LAG3 is associated with favorable overall survival of patients with solid tumors including ovarian, gastric, lymphoma, NSCLC, colorectal, and renal (48), as well as breast cancer.